Nlrp3 inflammasome inhibitors

TW202641526APending Publication Date: 2026-10-16NOVARTIS AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149923
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-11
Filing Date
2025-12-18
Publication Date
2026-10-16
Patent Text Reader

Abstract

The present disclosure relates to novel 2,2-difluoro-benzo-dioxole derivatives of formula (I): , wherein A1, A2, A3, A4, R1a, R1b, R2, R3a, R3b, R3c and R3d are defined herein, which inhibit NOD-like receptor protein
Need to check novelty before this filing date? Find Prior Art